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Abstract
In 2017, 3273 heart transplants were performed in the United States.
New listings continued to increase, and 3769 new adults were listed for
heart transplant in 2017. Over the past decade, posttransplant mortality
has declined. The number of new pediatric listings increased over the
past decade, as did the number of pediatric heart transplants, although
some fluctuation has occurred more recently. New listings for pediatric
heart transplants increased from 481 in 2007 to 623 in 2017. The number
of pediatric heart transplants performed each year increased from 330 in
2007 to 432 in 2017, slightly fewer than in 2016. Short-term and long-term
mortality improved. Among pediatric patients who underwent transplant
between 2015-2016, 4.8% had died by 6 months and 6.2% by 1 year.
Keywords: End-stage heart failure, heart transplant, transplant outcomes,
ventricular assist device.
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 1 Introduction
Themost significant occurrence in heart transplantation in recent years was approval
of the new heart allocation policy in 2016 and its implementation in October 2018.
This newalgorithmattempts to address broader sharing and risk stratification through
development of a 6-status system that combines Zone A and donation service area
(DSA) as the first point of allocation for higher urgency statuses. This important new
development also increased the data that OPTN will collect, with the goal of provid-
ing a dynamic policy that can continue to evolve over time. In addition, mechanical
circulatory support technology continues to improve, with newer pumps designed to
decrease risk of thrombosis. These improvements, if they result in better patient out-
comes, will likely affect future heart allocation policy. In this iteration of the annual
data report, we review the significant trends in heart transplantation in 2017.
2 Adult Heart Transplant
2.1 Waitlist Trends
Between 2006 and 2017, the number of new active listings for heart transplant in-
creased 49%, from 2424 to 3623 (Figure HR 1). Despite a decline between 2015 and
2017, the number of candidates actively awaiting heart transplant increased dramati-
cally since 2006, from 1243 to 2727 (Figure HR 2), an increase of 119%, suggesting that
transplant rates have not increased at the same rate as listings. The most remark-
able demographic trends in heart transplantation include the following: a continued
increase in the proportion of heart transplant candidates aged 65 years or older to
18.5% in 2017 (Figure HR 3); an increase in the proportion of racial/ethnic minorities,
with black candidates comprising 25.5% of patients awaiting heart transplant (Figure
HR 5); and a continued increase in patients with non-ischemic cardiomyopathy (Fig-
ure HR 6). The proportion of candidates with extended waiting times decreased. In
2006, 15.9% of candidates waited 5 years or more; this proportion gradually declined
to 4.1% in 2017 (Figure HR 7). The proportion of candidates awaiting transplant as
status 1A increased to 45.0% in 2017 (Figure HR 8). The proportion of status 1B can-
didates increased similarly, while the proportion waiting as status 2 declined from
29.8% to 15.7%. The proportion of candidates with ventricular assist devices (VADs)
at listing increased from 9.1% in 2006 to 32.6% in 2017(Figure HR 9). Sex distribution
has not changed (Figure HR 4). In 2017, 85.1% of candidates resided in a metropoli-
tan area (Table HR 1). The number of candidates listed for heart-kidney transplant
increased from 69 to 208 between 2007 and 2017, and the proportion of heart-lung
candidates declined to 1.2% (Table HR 3). The number of patients receiving circula-
tory support prior to transplant increased from 1610 in 2012 to 2427 in 2017 (Table
HR 6). Of these, 47.6% had left VADs (LVADs), which increased by 594 over the 5-year
period. The number of patients receiving IV inotropes increased by 224 and the num-
ber of those with intra-aortic balloon pumps (IABPs) increased by 115. The number
of patients with extracorporeal membrane oxygenation increased notably, from 15 to
32.
Between 2006 and 2017, heart transplant rates fluctuated, but overall remained
the same, 77.2 per 100 waitlist-years (Figure HR 14). The decade low of 61.5 per 100
waitlist-years occurred in 2015, andwas followedby an increase; this trendwas similar
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 for all age groups, racial/ethnic groups, blood types, and status groups (Figure HR 11,
Figure HR 12, Figure HR 13, Figure HR 14). Transplant rates peaked for most groups in
2006 and 2007, and reached a nadir in 2014 and 2015. Transplant rates by age group
remained similar, but varied widely by blood type andmedical urgency status. By age,
2017 transplant rates were highest for patients aged 65 or older and lowest for those
aged 35-49 years, 66.6 per 100 waitlist-years. Between 2006 and 2010, transplant
rates were highest for patients aged 18-34 yeas, but this shifted in 2011. Transplant
rates have consistently been highest for candidates with blood type AB (208.8 per
100 waitlist-years) and for those listed as status 1A (277.3 per 100 waitlist-years). In
2017, blood type O candidates underwent transplant at a rate of 52.9 per 100 waitlist-
years, nearly half the rate of blood type A and B candidates and 25% of the rate of
blood type AB candidates. Candidates with blood type A underwent transplant at a
rate of 105.7 per 100 waitlist-years, higher than in previous years, and higher than
candidates with blood type B. Transplant rates declined substantially for all status
groups between 2006 and 2015, but in 2017 appeared to be increasing again. In 2017,
candidates residing in non-metropolitan areas underwent transplant at slightly higher
rates than those in metropolitan areas, 80.5 per 100 waitlist-years vs. 76.8 (Figure
HR 15). Although trends based on candidate distance from the donor hospital have
been similar over the past decade, in 2017 candidates residing 150-250 nautical miles
(NM) from the donor hospital underwent transplant at the highest rate, 92.8 per 100
waitlist-years, and those residing 100-150 NM away at the lowest rate, 67.2 per 100
waitlist-years (Figure HR 16).
Multiple factors have contributed to the trends in transplant rates over the past
decade, and the variations may have been affected by policy changes and by changes
in program practices in response to policy changes and evolving mechanical circu-
latory support. The median waiting time in 2016-2017 was 7.9 months, an increase
from 4.0 months in 2006-2007 (Figure HR 18). Waiting times peaked in 2014-2015,
then declined again. In 2016-2017, median waiting time was longest for blood type O
candidates, 13.8 months (Figure HR 19), and candidates with body mass index ? 31
kg/m2, 12.2 months (Figure HR 21). Women waited on average 6.1 months, and men
8.4 months (Figure HR 18). Status 2 candidates had the longest median waiting times,
17.7months in 2016-2017 (FigureHR 20). Over the past decade, the proportion of can-
didates undergoing transplant within 1 year of listing declined overall, but appears to
be increasing since 2014. Of candidates listed in 2016, 56.3% underwent transplant
within 1 year (Figure HR 22). Geographic variability in transplant rates persisted, and
in 2017, the proportion of candidates undergoing transplant within 1 year varied from
23.1% to 94.1% depending on DSA (Figure HR 23). Similar variability occurred by state,
ranging from 20.0% to 100% (Figure HR 24).
Among candidates listed in 2014, 48.6% underwent transplant during the first year
on the waiting list, 33.8%were still waiting, 9.4%were removed from the list, and 8.2%
had died (Figure HR 17). At 3 years, 63.1% had undergone transplant, 9.7% were still
waiting, 17.4% had been removed from the list, and 9.8% had died. Despite slight
increases since 2016 in proportions of patients who were still waiting, who were re-
moved from the list, or who died, most patients undergo transplant within 3 years,
and less than 10.0% die on the waiting list. Between 2015 and 2017, fewer patients
were removed from the waiting list due to death and more were removed due to un-
dergoing transplant (Table HR 5).
Since 2006-2007, pretransplant mortality declined, from 16.3 to 12 deaths per 100
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 waitlist-years in 2016-2017 (Figure HR 25). Declines occurred in all age and racial/eth-
nic groups, with the most notable declines for candidates aged 18-34 years and black
and Hispanic candidates (Figure HR 25, Figure HR 26). Pretransplant mortality de-
clined notably for candidates with VADs at listing, from 47.8 to 11.8 deaths per 100
waitlist-years, nowmaking pretransplantmortality nearly identical for candidateswith
and without VADs at listing (Figure HR 30). Pretransplant mortality rates were high-
est for candidates listed as status 1A, but declined dramatically since 2005-2006, from
91.9 to 30.4 deaths per 100 waitlist-years (Figure HR 29). Similarly, pretransplant mor-
tality among candidates listed as status 1B declined from 36.3 to 8.1 deaths per 100
waitlist-years. Pretransplant mortality was slightly higher for candidates residing in
nonmetropolitan areas than for those in metropolitan areas (Figure HR 31).
Pretransplant mortality varied by DSA from 2.1 to 23.9 deaths per 100 waitlist-
years (Figure HR 33). Among candidates removed from the waiting list for reasons
other than transplant, 18.4% died within 6 months of removal. The proportion of
deaths within 6 months of removal from the waiting list fluctuated over the past
decade, peaking at 33.2% in 2013 (Figure HR 34). In 2017, 87 patients died within 6
months of removal from the waiting list. In 2017, 48.5% of candidates listed as status
1A died within 6 months of removal, reflecting the acuity of illness. The percentage
of candidates aged 18-34 years who died within 6 months decreased notably, from
21.0% in 2006 to 6.8% in 2017, and the percentage of candidates aged 65 years or
older who died within 6 months of removal increased from 20.0% in 2006 to 25.7% in
2017 (Figure HR 35).
2.2 Donor Trends
Deceased donor heart donations continued to increase, with 3272 donors in 2017, the
highest number to date, and an increase of 45% since 2006. The majority of these,
51.6%, were from donors aged 18-34 years (Figure HR 37), increasing from 1087 in
2007 to 1687 in 2017 (Figure HR 36). The rate of discards reached a nadir of 0.6%
between 2008 and 2011 and has trended upward since, with a slight downtrend in
2016-2017 (Figure HR 40). In 2016-2017, 1.0% of recovered hearts were not trans-
planted. The discard rate was highest among donors age 50 years or older, 2.7%. In
2016-2017, hearts from Public Health Service high-risk donors were discarded at a
lower rate, 0.8%, than hearts from donors not considered high risk, 1.1% (Figure HR
41).
The largest proportion of heart donor deaths, 47.1%, were caused by head trauma,
despite head trauma declining in prevalence from 63.3% in 2006. Anoxia continued
to increase as a cause of death among heart donors, and was 37.2% in 2017 from
14.0% in 2006 (Figure HR 42). While pediatric organs can be donated to adults, the
proportion of pediatric hearts transplanted into an adult is low, varying by state from
0% to 1% in 2017 (Figure HR 39).
2.3 Overall Trends in Heart Transplant
In 2017, 3273 heart transplants were performed, an increase of 64 since 2016; 432
transplants occurred in pediatric recipients and 2841 in adult recipients (FigureHR 43).
Over the past decade, adult heart transplants reached a nadir in 2008, and have been
increasing since, while pediatric transplants increased until 2015 and have declined by
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 28 since (Figure HR 43). The number of heart transplants increased in all age groups,
but the distribution increased more for recipients aged 65 years or older (Figure HR
44). Transplants increased in all racial/ethnic groups (Figure HR 46). In 2017, 66.4% of
adult heart transplants were performed in candidates listed as status 1A, compared
with 44.4% in 2007 (Table HR 8). In 2017, 85.0% of recipients resided in ametropolitan
area; 60.4% of recipients lived within 50 miles of the transplant program (Table HR
7). In 2017, 49.4% of recipients had LVADs. Although 25.2% of patients underwent
transplant within 31 days of listing in 2017, the proportion who underwent transplant
after waiting 1 year or more increased over the past decade: 21.7% in 2017 vs. 11.4%
in 2007 (Table HR 9). Dual organ transplant remained a small proportion of heart
transplants. The proportion of heart-lung transplants declined from 1.5% to 0.9%
between 2007 and 2017, heart-kidney transplants increased to 6.5% from 2.8%, and
heart-liver transplants increased from 0.5 to 1.0% (Table HR 9).
Use of induction therapy has changed little since 2006. In 2017, 52.4% of adult
heart transplant recipients received either IL2-RA or T-cell depleting therapy (Figure
HR 49). In 2017, 95.2% of recipients received a tacrolimus-based immunosuppression
regimen, while 3.6% received other regimens (Figure HR 50).
Transplant program volume has increased since 2006, with 50% of programs per-
forming at least 20 transplants per year in 2017 (Figure HR 53). In 2006, the median
volume was 12 transplants per year. The proportion of transplants performed at
higher- and lower-volume programs has shifted since 2006. In 2006, 10.8% of heart
transplants were performed at programs with fewer than 10 transplants per year,
compared with 3.6% in 2017. In contrast, 15.0% of transplants in 2006 were per-
formed at programs with 60 or more transplants per year, compared with 21.1% in
2017 (Figure HR 54).
2.4 Posttransplant Survival and Morbidity
Overall 1-year survival for patients who underwent heart transplant in 2010-2012 was
90.5%, 3-year survival was 84.1%, and 5-year survival was 79.1% (Figure HR 57). One-
year survival in most subgroups was similar, but tended to be lower among recipients
aged 65 years or older (Figure HR 55) and black recipients (Figure HR 56). Asian re-
cipients tended to have better survival at all time points. Survival at 1, 3, and 5 years
was similar between recipients with VADs and thosewithout circulatory support; how-
ever, survival was lower at 1, 3, and 5 years for recipients with IABPs, 88.4%, 80.4%,
and 75.0%, respectively. This reduction in survival for patients with IABPs occurred
as early as 1 month posttransplant (Figure HR 58). Survival among new transplants
and re-transplants was similar, except at 5 years, when survival was slightly better
for recipients undergoing re-transplant, 83.1% vs. 79.1% (Figure HR 59). Survival was
lower for recipients in non-metropolitan areas than for those in metropolitan areas
(Figure HR 61). Finally, while recipients residing 250 miles or farther from the trans-
plant program fared similarly to other recipients early after transplant, at 1, 3, and
5 years, their survival tended to be lower compared with survival of recipients living
closer to the transplant program. Five-year survival in this group was 74.2%, lowest of
all groups, followed by black recipients and recipients with IABPs (Figure HR 62). Since
2006, patient death after transplant has decreased overall at 6months and at 1, 3, and
5 years, despite slight increases between 2011 and 2014 (Figure HR 63). The number
of heart transplant survivors has increased by approximately 10,000 since 2006. On
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 June 30, 2017, 32,210 heart transplant recipients were alive with a functioning graft.
Most survivors had undergone transplant at age 50 years or older (Figure HR 64).
The incidence of acute rejection in the first year posttransplant was 25.4% for re-
cipients undergoing transplant in 2015-2016 (Figure HR 65). Posttransplant lympho-
proliferative disorder (PTLD) remained uncommon, with an overall cumulative inci-
dence of only 1.1% by 5 years posttransplant (Figure HR 67). The incidence was com-
paratively higher in recipients who were Epstein-Barre virus (EBV) seronegative, 1.1%,
1.9%, and 2.6% at 1, 3, and 5 years, respectively. The most common documented
cause of death in the first posttransplant year was infection (Figure HR 68); however,
by the second year, cardiovascular/cerebrovascular disease emerged as the leading
documented cause of death through year 5 (FigureHR 69). Malignancywas a relatively
infrequent cause of death, 1.4% of deaths at 5 years.
3 Pediatric Heart Transplant
3.1 Pediatric Waitlist Trends
In 2017, 623 new pediatric candidates were added to the heart transplant waiting list,
with few at inactive status (Figure HR 70). At year-end 2017, 384 candidates listed be-
fore their eighteenth birthdays were awaiting heart transplant, 68.0% active (Figure
HR 71). Over the past decade, the number of candidates with inactive status at year-
end decreased from 164 in 2007 to 123 in 2017. The largest pediatric age group on
the waiting list in 2017 was ages 11-17 years (34.4%), followed by ages younger than
1 year (27.0%), 1-5 years (24.8%), and 6-10 years (13.7%) (Figure HR 72). Almost half
of heart transplant candidates were white, 21.5% were Hispanic, 21.4% were black,
and 4.4% were Asian (Figure HR 73). Considering trends over time, the proportion of
waitlist candidates aged younger than 1 year increased from 9.6% on December 31,
2007, to 13.5% on December 31, 2017; the proportion of candidates aged 6-10 years
decreased from 23.7% to 16.7% over the same time period (Table HR 11). The propor-
tion of white candidates decreased from 61.4% on December 31, 2007, to 47.7% on
December 31, 2017. For candidates waiting on December 31, 2017, congenital defect
was the leading cause of heart disease (57.5%), increased from 45.0% in 2007 (Table
HR 12). The proportion of status 1B candidates increased from 9.2% in 2007 to 20.7%
in 2017. The differences in status 1A and 1B listing percentages are likely due in part
to changes to pediatric heart allocation policy implemented in 2016. The percentage
of candidates using VADs at the time of listing increased from 2.8% in 2007 to 8.0%
in 2017 (Table HR 12). Proportions of heart-only candidates increased from 91.2% at
year-end 2007 to 98.9% at year-end 2017 (Table HR 13). Among the 606 candidates
removed from the waiting list in 2017 (Table HR 14), 444 (73.3%) were removed due
to undergoing transplant, 67 (11.1%) died, 54 (8.9%) were removed due to improved
condition, and 28 (4.6%) were considered too sick to undergo transplant (Table HR
15).
Just over 70% of candidates newly listed in 2014 underwent transplant within 3
years, 12.1% died, 11.1% were removed from the list, and 5.1% were still waiting (Fig-
ure HR 78). The rate of heart transplants among pediatric waitlist candidates was
114.9 per 100 waitlist-years in 2017 (Figure HR 79). Transplant rates varied by age;
rates were highest for candidates aged younger than 1 year, at 192.0 transplants per
100 waitlist-years in 2017, followed by candidates aged 11-17 years, at 119.3 trans-
6
  
 plants per 100 waitlist-years (Figure HR 79). Pretransplant mortality decreased by half
over the past decade; 23.5 deaths per 100 waitlist-years in 2006-2007 to 11.9 deaths
per 100 waitlist-years in 2016-2017 (Figure HR 82). By age, pretransplant mortality
rates were highest for candidates aged younger than 1 year, at 41.2 deaths per 100
waitlist-years in 2016-2017. Rates were 7.2 deaths per 100 waitlist-years for candi-
dates aged 1-5 years, 5.1 for ages 6-10 years, and 7.6 for ages 11-17 years (Figure HR
82). Bymedical urgency status, pretransplantmortality was highest for status 1A (40.3
deaths per 100 waitlist-years) and 1B (15.0) candidates, compared with 5.5 for status
2 candidates (Figure HR 85).
3.2 Pediatric Trends in Heart Transplant
Pediatric transplant recipients are defined as those aged 18 years or younger at the
time of transplant. The number of pediatric heart transplants performed each year
increased from 321 in 2006 to 432 in 2017 (Figure HR 88). In 2017, 27 of 136 total heart
transplant programs performed pediatric heart transplants exclusively, 86 performed
adult heart transplants, and 23 performed both adult and pediatric heart transplants
(Figure HR 89). In 2017, 9.3% of transplants in recipients aged younger than 10 years
were performed at programs with volume of five or fewer pediatric transplants in
that year (Figure HR 90). Over the past decade, the age and sex of pediatric heart
transplant recipients changed little (Table HR 16).The proportion of recipients who
were white or black decreased and the proportion who were Hispanic increased (Ta-
ble HR 16). Congenital defects remained the most common primary cause of disease,
affecting 49.4% of recipients who underwent transplant in 2015-2017 (Table HR 17).
The proportion of patients who underwent transplant as status 1A increased from
74.8% in 2005-2007 to 82.9% in 2015-2017. VAD use doubled from 12.8% of trans-
plant recipients in 2005-2007 to 25.0% in 2015-2017 (Table HR 17). The proportion of
ABO-incompatible transplants in 2015-2017 was 7.5%, increased from 3.1% a decade
earlier (Table HR 18).
In 2017, use of T-cell depleting agents for induction continued to increase, to 72.0%
of heart transplant recipients; use of interleukin-2 receptor antagonists decreased
to 9.4% (Figure HR 91). The initial immunosuppression regimen used most com-
monly in 2017 was tacrolimus, mycophenolate (MMF), and steroid (54.2%), followed
by tacrolimus and MMF in 37.5% (Figure HR 92).
3.3 Pediatric Posttransplant Survival and Morbidity
Among pediatric heart transplant recipients 2015-2016, the rate of acute rejection
in the first year was 19.3% overall; the highest rate observed was 21.7% in the 6-10
year age group, and the lowest 17.5% in recipients aged younger than 6 years (Fig-
ure HR 96). Among pediatric heart transplant recipients 2013-2017, 60.6% were cy-
tomegalovirus (CMV) negative and 43.8% were EBV negative (Table HR 20). The com-
bination of a CMV-positive donor and CMV-negative recipient occurred in 28.5% of
transplants; for EBV, this combination occurred in 27.9% of transplants (Table HR 20).
Recipient death occurred in 4.8% of patients at 6 months posttransplant and in
6.2% at 1 year posttransplant among heart transplants performed in 2015-2016, in
12.0% at 3 years post-transplant for transplants performed in 2013-2014, in 15.2% at
5 years posttransplant for transplants performed in 2011-2012, and in 28.8% at 10
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 years posttransplant for transplants performed in 2007-2008 (Figure HR 98). Overall,
1-year and 5-year patient survival were 89.8% and 80.1%, respectively, among recip-
ients who underwent transplant in 2005-2012 (Figure HR 99). By age, 5-year patient
survival was 75.3% for recipients aged younger than 1 year, 81.5% for ages 1-5 years,
87.7% for ages 6-10 years, and 80.4% for ages 11-17 years (Figure HR 99). The lead-
ing identified causes of death in the first 12 months posttransplant were graft failure
(1.5%) and cardio/cerebrovascular disease (1.5%) (Figure HR 100). At 5 years post-
transplant, the leading causes were cardio/cerebrovascular disease (3.5%) and graft
failure (3.5%) (Figure HR 101).
The overall incidence of PTLDwas 4.0% at 5 years posttransplant, with 5.5% among
EBV-negative recipients and 2.7% among EBV-positive recipients (Figure HR 97).
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Figure HR 1. New adult candidates added to the heart transplant wait-
ing list. A new candidate is one who first joined the list during the given year,
without having been listed in a previous year. Previously listed candidateswho
underwent transplant and subsequently relisted are considered new. Candi-
dates concurrently listed at multiple centers are counted once. Active and in-
active patients are included.
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Figure HR 2. Adults listed for heart transplant on December 31 each year.
Candidates concurrently listed at multiple centers are counted once. Those
with concurrent listings and active at any program are considered active.
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Figure HR 3. Distribution of adults waiting for heart transplant by age.
Candidates waiting for transplant at any time in the given year. Candidates
listed concurrently at multiple centers are counted once. Age is determined
at the later of listing date or January 1 of the given year. Active and inactive
candidates are included.
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Figure HR 4. Distribution of adults waiting for heart transplant by sex.
Candidates waiting for transplant at any time in the given year. Candidates
listed concurrently at multiple centers are counted once. Active and inactive
patients are included.
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Figure HR 5. Distribution of adults waiting for heart transplant by race.
Candidates waiting for transplant at any time in the given year. Candidates
listed concurrently at multiple centers are counted once. Active and inactive
candidates are included.
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Figure HR 6. Distribution of adults waiting for heart transplant by diag-
nosis. Candidates waiting for transplant at any time in the given year. Can-
didates listed concurrently at multiple centers are counted once. Active and
inactive patients are included. CAD, coronary artery disease.
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FigureHR7. Distributionof adultswaiting for heart transplant bywaiting
time. Candidates waiting for transplant at any time in the given year. Candi-
dates listed concurrently at multiple centers are counted once. Time on the
waiting list is determined at the earlier of December 31 or removal from the
waiting list. Active and inactive candidates are included.
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Figure HR 8. Distribution of adults waiting for heart transplant by medi-
cal urgency. Candidates waiting for transplant at any time in the given year.
Candidates listed concurrently at multiple centers are counted once. Medical
urgency status is the most severe during the year. Active and inactive patients
are included.
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Figure HR 9. Distribution of adults waiting for heart transplant by VAD
status at listing. Candidates waiting for transplant at any time in the given
year. Candidates listed concurrently at multiple centers are counted once.
Active and inactive patients are included. VAD, ventricular assist device.
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Figure HR 10. Distribution of adults waiting for heart transplant by blood
type. Candidates waiting for transplant at any time in the given year. Can-
didates listed concurrently at multiple centers are counted once. Active and
inactive patients are included.
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Figure HR 11. Deceased donor heart transplant rates among adult wait-
list candidates by age. Transplant rates are computed as the number of de-
ceased donor transplants per 100 patient-years of wait time in a given year.
Individual listings are counted separately. Age is determined at the later of list-
ing date or January 1 of the given year. Rates with less than 10 patient-years
of exposure or fewer than 20 candidates at risk are not shown.
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Figure HR 12. Deceased donor heart transplant rates among adult wait-
list candidates by race. Transplant rates are computed as the number of de-
ceased donor transplants per 100 patient-years of wait time in a given year. In-
dividual listings are counted separately. Rates with less than 10 patient-years
of exposure or fewer than 20 candidates at risk are not shown.
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Figure HR 13. Deceased donor heart transplant rates among adult wait-
list candidates by blood type. Transplant rates are computed as the num-
ber of deceased donor transplants per 100 patient-years of wait time in a
given year. Individual listings are counted separately. Rates with less than 10
patient-years of exposure or fewer than 20 candidates at risk are not shown.
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Figure HR 14. Deceased donor heart transplant rates among adult wait-
list candidates by medical urgency. Transplant rates are computed as the
number of deceased donor transplants per 100 patient-years of wait time in
a given year. Individual listings are counted separately. Medical urgency is as-
sessed at the time of listing. Rates with less than 10 patient-years of exposure
or fewer than 20 candidates at risk are not shown.
16
  
 
2006 2008 2010 2012 2014 2016 2018
Year
0
20
40
60
80
10
0
Tr
an
sp
la
nt
s 
pe
r 
10
0 
w
ai
tli
st
 y
ea
rs
Metropolitan
Non-metropolitan
Figure HR 15. Deceased donor heart transplant rates amongwaitlist can-
didates bymetropolitan vs. non-metropolitan residence. Transplant rates
are computed as the number of deceased donor transplants per 100 patient-
years of wait time in a given year. Individual listings are counted separately.
Urban/rural determination is made using the RUCA (Rural-Urban Commut-
ing Area) designation of the candidate’s permanent zip code. Rates with less
than 10 patient-years of exposure or fewer than 20 candidates at risk are not
shown.
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Figure HR 16. Deceased donor heart transplant rates amongwaitlist can-
didates by distance from listing center. Transplant rates are computed as
the number of deceased donor transplants per 100 patient-years of wait time
in a given year. Individual listings are counted separately. Distance is nauti-
cal miles (NM) between the zip code centroids of the candidate’s listing center
and candidate’s permanent zip code. Rates with less than 10 patient-years of
exposure or fewer than 20 candidates at risk are not shown.
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Figure HR 17. Three-year outcomes for adults waiting for heart trans-
plant, new listings in 2014. Adults waiting for heart transplant and first listed
in 2014. Candidates concurrently listed at more than one center are counted
once, from the time of earliest listing to the time of latest removal. DD, de-
ceased donor.
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Figure HR 18. Medianmonths to heart transplant for waitlisted adults by
sex. Observations censored on December 31, 2017; Kaplan-Meier competing
riskmethods used to estimate time to transplant. Analysis performed per can-
didate, not per listing. If an estimate is not plotted, 50% of the cohort listed in
that year had not undergone transplant by the censoring date. Only the first
transplant is counted.
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Figure HR 19. Median months to heart transplant for waitlisted adults
by blood type. Observations censored on December 31, 2017; Kaplan-Meier
competing risk methods used to estimate time to transplant. Analysis per-
formed per candidate, not per listing. If an estimate is not plotted, 50% of the
cohort listed in that year had not undergone transplant by the censoring date.
Only the first transplant is counted.
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Figure HR 20. Medianmonths to heart transplant for waitlisted adults by
medical urgency at listing. Observations censored on December 31, 2017;
Kaplan-Meier competing risk methods used to estimate time to transplant.
Analysis performed per candidate, not per listing. If an estimate is not plot-
ted, 50% of the cohort listed in that year had not undergone transplant by the
censoring date. Only the first transplant is counted.
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Figure HR 21. Median months to heart transplant for waitlisted adults
by BMI at listing. Observations censored on December 31, 2017; Kaplan-
Meier competing risk methods used to estimate time to transplant. Analysis
performed per candidate, not per listing. If an estimate is not plotted, 50% of
the cohort listed in that year had not undergone transplant by the censoring
date. Only the first transplant is counted.
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FigureHR 22. Percentage of adultswhounderwent deceased donor heart
transplant within a given time period of listing. Candidates concurrently
listed at more than one center are counted once, from the time of earliest
listing to the time of latest removal.
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FigureHR 23. Percentage of adultswhounderwent deceased donor heart
transplant within 1 year of listing in 2016 by DSA. Candidates listed concur-
rently in a single DSA are counted once in that DSA, from the time of earliest
listing to the time of latest removal; candidates listed in multiple DSAs are
counted separately per DSA.
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FigureHR 24. Percentage of adultswhounderwent deceased donor heart
transplantwithin 1 year of listing in 2016by state. Candidates concurrently
listed at more than one center are counted once, from the time of earliest
listing to the time of latest removal.
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Figure HR 25. Pretransplant mortality rates among adults waitlisted for
heart transplant by age. Mortality rates are computed as the number of
deaths per 100 patient-years of waiting in the given year. Waiting time is cen-
sored at transplant, death, transfer to another program, removal because of
improved condition, or end of cohort. Individual listings are counted sepa-
rately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown. Age is determined at the later of listing date
or January 1 of the given year.
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Figure HR 26. Pretransplant mortality rates among adults waitlisted for
heart transplant by race. Mortality rates are computed as the number of
deaths per 100 patient-years of waiting in the given year. Waiting time is cen-
sored at transplant, death, transfer to another program, removal because of
improved condition, or end of cohort. Individual listings are counted sepa-
rately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown.
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Figure HR 27. Pretransplant mortality rates among adults waitlisted for
heart transplant by sex. Mortality rates are computed as the number of
deaths per 100 patient-years of waiting in the given year. Waiting time is cen-
sored at transplant, death, transfer to another program, removal because of
improved condition, or end of cohort. Individual listings are counted sepa-
rately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown.
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Figure HR 28. Pretransplant mortality rates among adults waitlisted for
heart transplant by diagnosis. Mortality rates are computed as the number
of deaths per 100 patient-years of waiting in the given year. Waiting time is
censored at transplant, death, transfer to another program, removal because
of improved condition, or end of cohort. Individual listings are counted sep-
arately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown. CAD, coronary artery disease.
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Figure HR 29. Pretransplant mortality rates among adults waitlisted for
heart transplant by medical urgency. Mortality rates are computed as the
number of deaths per 100 patient-years of waiting in the given year. Wait-
ing time is censored at transplant, death, transfer to another program, re-
moval because of improved condition, or end of cohort. Individual listings are
counted separately. Rateswith less than 10 patient-years of exposure or fewer
than 20 candidates at risk are not shown. Medical urgency is determined at
the later of listing date and January 1 of the year.
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Figure HR 30. Pretransplant mortality rates among adults waitlisted for
heart transplant byVADat listing. Mortality rates are computed as the num-
ber of deaths per 100 patient-years of waiting in the given year. Waiting time is
censored at transplant, death, transfer to another program, removal because
of improved condition, or end of cohort. Individual listings are counted sep-
arately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown. VAD, ventricular assist device.
24
  
 
2006 2008 2010 2012 2014 2016
Year
0
5
10
20
30
D
ea
th
s 
pe
r 
10
0 
w
ai
tli
st
 y
ea
rs
Metropolitan
Non-metropolitan
Figure HR 31. Pretransplant mortality rates among adults waitlisted for
heart by metropolitan vs. non-metropolitan residence. Mortality rates
are computed as the number of deaths per 100 patient-years of waiting in the
given year. Waiting time is censored at transplant, death, transfer to another
program, removal because of improved condition, or end of cohort. Individual
listings are counted separately. Rates with less than 10 patient-years of expo-
sure or fewer than 20 candidates at risk are not shown. Urban/rural determi-
nation is made using the RUCA (Rural-Urban Commuting Area) designation of
the candidate’s permanent zip code.
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Figure HR 32. Pretransplant mortality rates among adults waitlisted for
heart, by distance from listing center. Mortality rates are computed as the
number of deaths per 100 patient-years of waiting in the given year. Wait-
ing time is censored at transplant, death, transfer to another program, re-
moval because of improved condition, or end of cohort. Individual listings are
counted separately. Rateswith less than 10 patient-years of exposure or fewer
than 20 candidates at risk are not shown. Distance is nautical miles (NM) be-
tween the zip code centroids of the candidate’s listing center and candidate’s
permanent zip code.
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Figure HR 33. Pretransplant mortality rates among adults waitlisted for
heart transplant in 2016-2017, by DSA.Mortality rates are computed as the
number of deaths per 100 patient-years of waiting in the DSA. Waiting time is
censored at transplant, death, transfer to another program, removal because
of improved condition, or end of cohort. Individual listings are counted sepa-
rately. Rates with less than 10 patient-years of exposure are not shown.
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Figure HR 34. Deaths within sixmonths after removal among adult heart
waitlist candidates, by status at removal. Denominator includes only can-
didates removed from the waiting list for reasons other than transplant or
death while on the list.
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Figure HR 35. Deaths within sixmonths after removal among adult heart
waitlist candidates, by age at removal. Denominator includes only candi-
dates removed from thewaiting list for reasons other than transplant or death
while on the list.
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Figure HR 36. Deceased heart donor count by age. Count of deceased
donors whose hearts were recovered for transplant, by age at donation.
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Figure HR 37. Distribution of deceased heart donors by age. Deceased
donors whose hearts were recovered for transplant.
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Figure HR 38. Distribution of deceased heart donors by race. Deceased
donors whose hearts were recovered for transplant.
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Figure HR 39. Percent of pediatric heart donors allocated to adult recip-
ients. Numerator: pediatric heart and heart-lung donors allocated to adult
recipients. Denominator: total pediatric heart and heart-lung donors
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Figure HR 40. Rates of hearts recovered for transplant and not trans-
planted by donor age. Percentages of hearts not transplanted out of all
hearts recovered for transplant.
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Figure HR 41. Rates of hearts recovered for transplant and not trans-
planted, by donor risk of disease transmission. ”Increased risk” is defined
by criteria from the US Public Health Service Guidelines for increased risk for
HIV, hepatitis B and hepatitis C transmission.
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Figure HR 42. Cause of death among deceased heart donors. Deceased
donors whose hearts were transplanted. CNS, central nervous system; CVA,
cerebrovascular accident.
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Figure HR 43. Total heart transplants. All heart transplant recipients, in-
cluding adult and pediatric, retransplant, and multi-organ recipients.
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FigureHR 44. Total heart transplants by age. All heart transplant recipients,
including adult and pediatric, retransplant, and multi-organ recipients.
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FigureHR 45. Total heart transplants by sex. All heart transplant recipients,
including adult and pediatric, retransplant, and multi-organ recipients.
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Figure HR 46. Total heart transplants by race. All heart transplant recipi-
ents, including adult and pediatric, retransplant, and multi-organ recipients.
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Figure HR 47. Total heart transplants by diagnosis. All heart transplant
recipients, including adult and pediatric, retransplant, and multi-organ recipi-
ents. CAD, coronary artery disease.
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Figure HR 48. Total heart transplants by medical urgency. All heart trans-
plant recipients, including adult and pediatric, retransplant, and multi-organ
recipients.
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Figure HR 49. Induction agent use in adult heart transplant recipients.
Immunosuppression at transplant reported to the OPTN. IL2-RA, interleukin-2
receptor antagonist.
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Figure HR 50. Immunosuppression regimen use in adult heart transplant
recipients. Immunosuppression regimen at transplant reported to the OPTN.
Tac, tacrolimus. MMF, mycophenolate mofetil.
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Figure HR 51. Total HLA A, B, and DR mismatches among adult deceased
donor heart transplant recipients, 2013-2017. Donor and recipient antigen
matching is based on OPTN antigen values and split equivalences policy as of
2016.
0
20
40
60
1A 1B 2
Pe
rc
en
t <50
³ 50
³ 60
³ 65
Figure HR 52. Status of adult heart transplant recipients, 2015-2017, by
age. Age categories are not exclusive. All recipients aged 65 or older, for ex-
ample, are also included among those aged 60 or older and 50 or older.
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Figure HR 53. Annual adult heart transplant center volumes, by per-
centile. Annual volume data are limited to recipients aged 18 or older.
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Figure HR 54. Distribution of adult heart transplants by annual center
volume. Based on annual volume data among recipients aged 18 or older.
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Figure HR 55. Patient survival among adult heart transplant recipients,
2010-2012, by age. Patient survival estimated using unadjusted Kaplan-Meier
methods. For recipients of more than one transplant during the period, only
the first is considered.
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Figure HR 56. Patient survival among adult heart transplant recipients,
2010-2012, by race. Patient survival estimated using unadjusted Kaplan-
Meier methods. For recipients of more than one transplant during the period,
only the first is considered.
38
  
 
0 12 24 36 48 60
Months posttransplant
75
80
85
90
95
10
0
Pe
rc
en
t
Female
Male
All
Figure HR 57. Patient survival among adult heart transplant recipients,
2010-2012, by sex. Patient survival estimated using unadjusted Kaplan-Meier
methods. For recipients of more than one transplant during the period, only
the first is considered.
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Figure HR 58. Patient survival among adult heart transplant recipients,
2010-2012, by circulatory support. Patient survival estimated using unad-
justed Kaplan-Meier methods. For recipients of more than one transplant
during the period, only the first is considered. Ventricular assist device (VAD)
status at time of transplant. IABP, intra-aortic balloon pump.
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Figure HR 59. Patient survival among adult heart transplant recipients,
2010-2012, by first vs. retransplant. Patient survival estimated using un-
adjusted Kaplan-Meier methods. For recipients of more than one transplant
during the period, only the first is considered.
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Figure HR 60. Patient survival among adult heart transplant recipients,
2010-2012, bymedical urgency. Patient survival estimated using unadjusted
Kaplan-Meier methods. For recipients of more than one transplant during the
period, only the first is considered.
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Figure HR 61. Patient survival among adult heart transplant recipients,
2010-2012, by metropolitan vs. non-metropolitan recipient residence.
Patient survival estimated using unadjusted Kaplan-Meier methods. For re-
cipients of more than one transplant during the period, only the first is con-
sidered.
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Figure HR 62. Patient survival among adult heart transplant recipients,
2010-2012, by recipients’ distance from transplant center. Patient survival
estimated using unadjusted Kaplan-Meier methods. For recipients of more
than one transplant during the period, only the first is considered. Distance is
between the zipcode centroids of the TX center and the recipient’s permanent
residence, measured in nautical miles (NM).
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Figure HR 63. Patient death among adult heart transplant recipients. All
adult recipients of deceased donor hearts, including multi-organ transplants.
Patients are followed until the earlier of death or December 31, 2017. Esti-
mates computed with Cox proportional hazards models adjusted for age, sex,
and race.
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Figure HR 64. Recipients alive with a functioning heart graft on June 30
of the year, by age at transplant. Recipients are assumed to be alive with
function unless a death or graft failure is recorded. A recipientmay experience
a graft failure and be removed from the cohort, undergo retransplant, and re-
enter the cohort.
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Figure HR 65. Incidence of acute rejection by 1 year posttransplant
among adult heart transplant recipients by age, 2015-2016. Acute rejec-
tion is defined as a record of acute or hyperacute rejection, as reported on
the OPTN Transplant Recipient Registration or Transplant Recipient Follow-up
Form. Only the first rejection event is counted. Cumulative incidence is esti-
mated using the Kaplan-Meier competing risk method.
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Figure HR 66. Incidence of acute rejection by 1 year posttransplant
among adult heart transplant recipients by induction status, 2015-2016.
Acute rejection is defined as a record of acute or hyperacute rejection, as re-
ported on the OPTN Transplant Recipient Registration or Transplant Recipient
Follow-up Form. Only the first rejection event is counted. Cumulative inci-
dence is estimated using the Kaplan-Meier competing risk method. If a recip-
ient used both IL-2-RA and TCD agents, s/he will contribute to both of those
cumulative incidence estimates.
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Figure HR 67. Incidence of PTLD among adult heart transplant recipients
by recipient EBV status at transplant, 2011-2015. Cumulative incidence is
estimated using the Kaplan-Meier competing risk method. PTLD is identified
as a reported complication or cause of death on the OPTN Transplant Recip-
ient Follow-up Form or the Posttransplant Malignancy Form as polymorphic
PTLD, monomorphic PTLD, or Hodgkin disease. Only the earliest date of PTLD
diagnosis is considered. EBV, Epstein-Barr virus; PTLD, posttransplant lym-
phoproliferative disorder.
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Figure HR 68. One-year cumulative incidence of death by cause among
adult heart recipients, 2015-2016. Primary cause of death is as reported
on the OPTN Transplant Recipient Registration and Follow-up Forms. Other
causes of death include hemorrhage, trauma, nonadherence, unspecified
other, unknown, etc. Cumulative incidence is estimated using Kaplan-Meier
competing risk methods.
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Figure HR 69. Five-year cumulative incidence of death by cause among
adult heart recipients, 2011-2012. Primary cause of death is as reported
on the OPTN Transplant Recipient Registration and Follow-up Forms. Other
causes of death include hemorrhage, trauma, nonadherence, unspecified
other, unknown, etc. Cumulative incidence is estimated using Kaplan-Meier
competing risk methods.
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Figure HR 70. New pediatric candidates added to the heart transplant
waiting list. A new candidate is one who first joined the list during the given
year, without having been listed in a previous year. Previously listed candi-
dates who underwent transplant and subsequently relisted are considered
new. Candidates concurrently listed at multiple centers are counted once. Ac-
tive and inactive patients are included. Age determined at listing.
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Figure HR 71. Pediatric candidates listed for heart transplant on De-
cember 31 each year. Candidates concurrently listed at multiple centers are
counted once. Those with concurrent listings and active at any program are
considered active.
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FigureHR72. Distribution of pediatric candidateswaiting for heart trans-
plant by age. Candidates waiting for transplant at any time in the given year.
Candidates listed concurrently at multiple centers are counted once. Age is
determined at the later of listing date or January 1 of the given year. Active
and inactive candidates are included.
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FigureHR73. Distribution of pediatric candidateswaiting for heart trans-
plant by race. Candidates waiting for transplant any time in the given year.
Candidates listed concurrently at multiple centers are counted once. Active
and inactive candidates are included.
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FigureHR74. Distribution of pediatric candidateswaiting for heart trans-
plant by diagnosis. Candidates waiting for transplant any time in the given
year. Candidates listed concurrently at multiple centers are counted once. Ac-
tive and inactive candidates are included. CM, cardiomyopathy.
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FigureHR75. Distribution of pediatric candidateswaiting for heart trans-
plant by sex. Candidates waiting for transplant any time in the given year.
Candidates listed concurrently at multiple centers are counted once. Active
and inactive patients are included.
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FigureHR76. Distribution of pediatric candidateswaiting for heart trans-
plant bywaiting time. Candidateswaiting for transplant any time in the given
year. Candidates listed concurrently at multiple centers are counted once.
Time on thewaiting list is determined at the earlier of December 31 or removal
from the waiting list. Active and inactive candidates are included.
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FigureHR77. Distribution of pediatric candidateswaiting for heart trans-
plant by medical urgency. Candidates waiting for transplant any time in the
given year. Candidates listed concurrently at multiple centers are counted
once. Medical urgency status is the most severe during the year. Active and
inactive patients are included.
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Figure HR 78. Three-year outcomes for newly listed pediatric candidates
waiting for heart transplant, 2014. Pediatric candidates who joined the
waitlist in 2014. Candidates concurrently listed at more than one center are
counted once, from the time of earliest listing to the time of latest removal.
DD, deceased donor.
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Figure HR 79. Heart transplant rates among pediatric waitlist candidates
by age. Transplant rates are computed as the number of deceased donor
transplants per 100 patient-years of waiting in a given year. Individual listings
are counted separately. Age is determined at the later of listing date or January
1 of the given year. Rates with less than 10 patient-years of exposure or fewer
than 20 candidates at risk are not shown.
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Figure HR 80. Deceased donor heart transplant rates among pediatric
waitlist candidates by metropolitan vs. non-metropolitan residence.
Transplant rates are computed as the number of deceased donor transplants
per 100 patient-years of waiting in a given year. Individual listings are counted
separately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown.
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Figure HR 81. Deceased donor heart transplant rates among pediatric
waitlist candidates by distance from listing center. Transplant rates are
computed as the number of deceased donor transplants per 100 patient-years
of waiting in a given year. Individual listings are counted separately. Rateswith
less than 10 patient-years of exposure or fewer than 20 candidates at risk are
not shown. Distance is between the zipcode centroids of the TX center and
the recipient’s permanent residence, measured in nautical miles (NM).
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Figure HR 82. Pretransplant mortality rates among pediatrics waitlisted
for heart transplant by age. Mortality rates are computed as the number
of deaths per 100 patient-years of waiting in the given year. Waiting time
is censored at transplant, death, transfer to another program, removal be-
cause of improved condition, or end of cohort. Individual listings are counted
separately. Age is determined at the later of listing date or January 1 of the
given year. Individual listings are counted separately. Rates with less than 10
patient-years of exposure or fewer than 20 candidates at risk are not shown.
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Figure HR 83. Pretransplant mortality rates among pediatrics waitlisted
for heart transplant by race. Mortality rates are computed as the number
of deaths per 100 patient-years of waiting in the given year. Waiting time is
censored at transplant, death, transfer to another program, removal because
of improved condition, or end of cohort. Individual listings are counted sep-
arately. Rates with less than 10 patient-years of exposure or fewer than 20
candidates at risk are not shown.
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Figure HR 84. Pretransplant mortality rates among pediatrics waitlisted
for heart transplant by diagnosis. Mortality rates are computed as the num-
ber of deaths per 100 patient-years of waiting in the given year. Waiting time is
censored at transplant, death, transfer to another program, removal because
of improved condition, or end of cohort. Individual listings are counted sepa-
rately. Rates with less than 10 patient-years of exposure are not shown. CM,
cardiomyopathy.
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Figure HR 85. Pretransplant mortality rates among pediatrics waitlisted
for heart transplant by medical urgency. Transplant rates are computed
as the number of deceased donor transplants per 100 patient-years of active
waiting in a given year. Individual listings are counted separately. Rates with
less than 10 patient-years of exposure or fewer than 20 candidates at risk are
not shown. Medical urgency status is determined at the later of listing date
and January 1 of the given year.
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Figure HR 86. Pretransplant mortality rates among pediatrics waitlisted
for heart transplant by metropolitan vs. non-metropolitan residence.
Mortality rates are computed as the number of deaths per 100 patient-years
of waiting in the given year. Waiting time is censored at transplant, death,
transfer to another program, removal because of improved condition, or end
of cohort. Individual listings are counted separately. Rates with less than 10
patient-years of exposure are not shown. CM, cardiomyopathy.
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Figure HR 87. Pretransplant mortality rates among pediatrics waitlisted
for heart transplant by distance from listing center. Transplant rates are
computed as the number of deceased donor transplants per 100 patient-years
of active waiting in a given year. Individual listings are counted separately.
Rates with less than 10 patient-years of exposure or fewer than 20 candidates
at risk are not shown. Medical urgency status is determined at the later of
listing date and January 1 of the given year.
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Figure HR 88. Pediatric heart transplants by recipient age. All pediatric
heart transplant recipients, including retransplant, andmulti-organ recipients.
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Figure HR 89. Number of centers performing pediatric and adult heart
transplants by center’s age mix. Adult centers transplanted only recipi-
ents aged 18 years or older. Functionally adult centers transplant 80% adults
or more, and the remainder were children aged 15-17 years. Mixed in-
cluded adults and children of any age groups. Child only centers transplanted
recipeints aged 0-17 years, and small number of adults up to age 21 years.
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Figure HR 90. Pediatric heart recipients at programs that perform 5 or
fewer pediatric transplants annually. Age groups are cumulative.
55
  
 
2006 2008 2010 2012 2014 2016 2018
Year
0
20
40
60
80
Pe
rc
en
t
IL2-RA
T-cell depleting
None
Figure HR 91. Induction agent use in pediatric heart transplant re-
cipients. Immunosuppression at transplant reported to the OPTN. IL2-RA,
interleukin-2 receptor antagonist.
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Figure HR 92. Immunosuppression regimen use in pediatric heart trans-
plant recipients. Immunosuppression regimen at transplant reported to the
OPTN. Tac, tacrolimus. MMF, mycophenolate mofetil.
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Figure HR 93. Induction use by C/PRA among pediatric heart transplant
recipients, 2013-2017. Collection of calculated PRA (CPRA) began March 31,
2015. Prior to that, PRA class I and II values were used. IL2-RA, interleukin-2
receptor antagonist.
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Figure HR 94. Total HLA A, B, and DR mismatches among pediatric de-
ceased donor heart transplant recipients, 2013-2017. Donor and recipient
antigen matching is based on OPTN antigen values and split equivalences pol-
icy as of 2016.
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Figure HR 95. Incidence of acute rejection by 1 year posttransplant
among pediatric heart transplant recipients by induction status, 2015-
2016. Acute rejection is defined as a record of acute or hyperacute rejection,
as reported on the OPTN Transplant Recipient Registration or Transplant Re-
cipient Follow-up Form. Only the first rejection event is counted. Cumulative
incidence is estimated using the Kaplan-Meier competing risk method. If a re-
cipient used both IL-2-RA and TCD agents, s/he will contribute to both of those
cumulative incidence estimates.
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Figure HR 96. Incidence of acute rejection by 1 year posttransplant
among pediatric heart transplant recipients by age, 2015-2016. Acute re-
jection is defined as a record of acute or hyperacute rejection, as reported
on the OPTN Transplant Recipient Registration Form or Transplant Recipient
Follow-up Form. Only the first rejection event is counted. Cumulative inci-
dence is estimated using the Kaplan-Meier competing risk method.
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Figure HR 97. Incidence of PTLD among pediatric heart transplant recip-
ients by recipient EBV status at transplant, 2004-2014. Cumulative inci-
dence is estimated using the Kaplan-Meier competing risk method. Posttrans-
plant lymphoproliferative disorder (PTLD) is identified as a reported complica-
tion or cause of death on the OPTN Transplant Recipient Follow-up Form or
on the Posttransplant Malignancy Form as polymorphic PTLD, monomorphic
PTLD, or Hodgkin disease. Only the earliest date of PTLD diagnosis is consid-
ered. EBV, Epstein-Barr virus.
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Figure HR 98. Patient death among pediatric heart transplant recipients.
All pediatric recipients of deceased donor hearts, including multi-organ trans-
plants. Patients are followed until the earlier of death or December 31, 2017.
Estimates computed with Cox proportional hazards models adjusted for age,
sex, and race.
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Figure HR 99. Patient survival among pediatric deceased donor heart
transplant recipients, 2005-2012, by recipient age. Recipient survival es-
timated using unadjusted Kaplan-Meier methods.
0 2 4 6 8 10 12
Months since transplant
0.
0
0.
5
1.
0
1.
5
2.
0
Pe
rc
en
t Graft failure
Infection
Cardio/cerebrovascular
Malignancy
Respiratory
Figure HR 100. One-year cumulative incidence of death by cause among
pediatric heart recipients, 2015-2016. Primary cause of death is as re-
ported on the OPTN Transplant Recipient Registration and Follow-up Forms.
Other causes of death include hemorrhage, trauma, nonadherence, unspec-
ified other, unknown, etc. Cumulative incidence is estimated using Kaplan-
Meier competing risk methods.
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Figure HR 101. Five-year cumulative incidence of death by cause among
pediatric heart recipients, 2011-2012. Primary cause of death is as re-
ported on the OPTN Transplant Recipient Registration and Follow-up Forms.
Other causes of death include hemorrhage, trauma, nonadherence, unspec-
ified other, unknown, etc. Cumulative incidence is estimated using Kaplan-
Meier competing risk methods.
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Characteristic 2007 2017N Percent N Percent
Age
18-34 years 246 10.2% 387 11.0%
35-49 years 542 22.4% 829 23.5%
50-64 years 1276 52.8% 1651 46.8%
≥ 65 years 353 14.6% 662 18.8%
Sex
Female 595 24.6% 865 24.5%
Male 1822 75.4% 2664 75.5%
Race/ethnicity
White 1768 73.1% 2146 60.8%
Black 404 16.7% 952 27.0%
Hispanic 177 7.3% 314 8.9%
Asian 49 2.0% 98 2.8%
Other/unknown 19 0.8% 19 0.5%
Geography
Metropolitan 1943 80.4% 3004 85.1%
Non-metro 474 19.6% 525 14.9%
Distance
< 50 miles 1382 57.2% 2164 61.3%
50-<100 miles 418 17.3% 569 16.1%
100-<150 miles 239 9.9% 332 9.4%
150-<250 miles 179 7.4% 223 6.3%
≥ 250 miles 173 7.2% 219 6.2%
Unknown 26 1.1% 22 0.6%
All candidates 2417 100.0% 3529 100.0%
Table HR 1Demographic characteristics of adults on the heart transplant
waiting list on December 31, 2007 and December 31, 2017. Candidates
waiting for transplant on December 31, 2007, and December 31, 2017, regard-
less of first listing date; multiple listings are collapsed.
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Characteristic 2007 2017N Percent N Percent
Diagnosis
Coronary artery disease 1012 41.9% 1124 31.9%
Cardiomyopathy 1076 44.5% 2009 56.9%
Congenital disease 135 5.6% 181 5.1%
Valvular disease 57 2.4% 34 1.0%
Other/unknown 137 5.7% 181 5.1%
Blood type
A 762 31.5% 1059 30.0%
B 228 9.4% 400 11.3%
AB 38 1.6% 69 2.0%
O 1389 57.5% 2001 56.7%
Medical urgency
Status 1A 90 3.7% 378 10.7%
Status 1B 319 13.2% 1555 44.1%
Status 2 899 37.2% 794 22.5%
Inactive status 1109 45.9% 802 22.7%
VAD at listing 144 6.0% 1191 33.7%
All candidates 2417 100.0% 3529 100.0%
Table HR 2 Clinical characteristics of adults on the heart transplant wait-
ing list on December 31, 2007 and December 31, 2017. Candidates waiting
for transplant on December 31, 2007, and December 31, 2017, regardless of
first listing date; multiple listings are collapsed. VAD, ventricular assist device.
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Characteristic 2007 2017N Percent N Percent
Transplant history
First 2332 96.5% 3404 96.5%
Retransplant 85 3.5% 125 3.5%
Wait time
< 1 year 1019 42.2% 1825 51.7%
1-< 2 years 350 14.5% 722 20.5%
2-< 3 years 187 7.7% 393 11.1%
3-< 4 years 155 6.4% 251 7.1%
4-< 5 years 134 5.5% 119 3.4%
≥ 5 years 572 23.7% 219 6.2%
Tx type
Heart only 2249 93.0% 3243 91.9%
Heart-kidney 69 2.9% 208 5.9%
Heart-lung 82 3.4% 41 1.2%
Other 17 0.7% 37 1.0%
All candidates 2417 100.0% 3529 100.0%
Table HR 3 Listing characteristics of adults on the heart transplant wait-
ing list on December 31, 2007 and December 31, 2017. Candidates waiting
for transplant on December 31, 2007, and December 31, 2017, regardless of
first listing date; multiple listings are collapsed.
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Waiting list state 2015 2016 2017
Patients at start of year 3626 3790 3629
Patients added during year 3622 3629 3769
Patients removed during year 3454 3783 3869
Patients at end of year 3794 3636 3529
Table HR 4 Heart transplant waitlist activity among adults. Candidates
concurrently listed at more than one center are counted once, from the time
of earliest listing to the time of latest removal. Candidates who are listed, un-
dergo transplant, and are relisted are counted more than once. Candidates
are not considered to be on the list on the day they are removed; counts on
January 1 may differ from counts on December 31 of the prior year. Candi-
dates listed for multi-organ transplants are included.
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Removal reason 2015 2016 2017
Deceased donor transplant 2331 2734 2811
Patient died 395 324 290
Patient refused transplant 24 25 27
Improved, transplant not needed 161 187 176
Too sick for transplant 297 261 290
Other 246 251 273
TableHR 5Removal reason among adult heart transplant candidates. Re-
moval reason as reported to the OPTN. Candidates with death dates that pre-
cede removal dates are assumed to have died waiting.
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Support 2012 2017N Percent N Percent
Any life support 1610 79.1% 2427 85.4%
Intravenous inotropes 789 38.8% 1013 35.7%
Left ventricular assist device 759 37.3% 1353 47.6%
Intra-aortic balloon pump 121 5.9% 236 8.3%
Right ventricular assist device 53 2.6% 46 1.6%
Ventilator 22 1.1% 22 0.8%
Total artificial heart 21 1.0% 23 0.8%
Extra corporeal membrane oxygenation 15 0.7% 32 1.1%
Prostaglandins 15 0.7% 1 0.0%
Inhaled NO 4 0.2% 5 0.2%
Table HR 6 Adult heart recipients on circulatory support before trans-
plant. Patients may have more than one type of circulatory support.
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Characteristic 2007 2017N Percent N Percent
Age
18-34 years 244 12.8% 317 11.2%
35-49 years 454 23.8% 580 20.4%
50-64 years 966 50.6% 1370 48.2%
≥ 65 years 246 12.9% 574 20.2%
Sex
Female 453 23.7% 742 26.1%
Male 1457 76.3% 2099 73.9%
Race/ethnicity
White 1326 69.4% 1791 63.0%
Black 368 19.3% 676 23.8%
Hispanic 149 7.8% 247 8.7%
Asian 53 2.8% 112 3.9%
Other/unknown 14 0.7% 15 0.5%
Insurance
Private 1032 54.0% 1337 47.1%
Medicare 521 27.3% 1033 36.4%
Medicaid 267 14.0% 370 13.0%
Other government 66 3.5% 88 3.1%
Unknown 24 1.3% 13 0.5%
Geography
Metropolitan 1589 83.2% 2414 85.0%
Non-metro 321 16.8% 427 15.0%
Distance
< 50 miles 1159 60.7% 1717 60.4%
50-<100 miles 318 16.6% 489 17.2%
100-<150 miles 155 8.1% 223 7.8%
150-<250 miles 134 7.0% 231 8.1%
≥ 250 miles 117 6.1% 164 5.8%
Unknown 27 1.4% 17 0.6%
All recipients 1910 100.0% 2841 100.0%
Table HR 7 Demographic characteristics of adult heart transplant recip-
ients, 2007 and 2017. Adult heart transplant recipients, including retrans-
plants.
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Characteristic 2007 2017N Percent N Percent
Diagnosis
Coronary artery disease 790 41.4% 852 30.0%
Cardiomyopathy 996 52.1% 1797 63.3%
Congenital disease 56 2.9% 92 3.2%
Valvular disease 34 1.8% 29 1.0%
Other/unknown 34 1.8% 71 2.5%
Blood type
A 782 40.9% 1165 41.0%
B 273 14.3% 408 14.4%
AB 105 5.5% 162 5.7%
O 750 39.3% 1106 38.9%
Medical urgency
Status 1A 848 44.4% 1886 66.4%
Status 1B 762 39.9% 885 31.2%
Status 2 300 15.7% 70 2.5%
On VAD 497 26.0% 1404 49.4%
CPRA
< 1% 1241 65.0% 1276 44.9%
1-< 20% 290 15.2% 356 12.5%
20-< 80% 194 10.2% 457 16.1%
80-< 98% 41 2.1% 111 3.9%
98-100% 22 1.2% 38 1.3%
Unknown 122 6.4% 603 21.2%
All recipients 1910 100.0% 2841 100.0%
Table HR 8 Clinical characteristics of adult heart transplant recipients,
2007 and 2017. Adult heart transplant recipients, including retransplants.
Ventricular assist device (VAD) information is from the OPTN Transplant Re-
cipient Registration Form and includes left VAD, right VAD, total artificial heart,
and left + right VAD. Collection of calculated PRA (CPRA) beganMarch 31, 2015.
Prior to that, PRA class I and II values were used.
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Characteristic 2007 2017N Percent N Percent
Wait time
< 31 days 731 38.3% 717 25.2%
31-60 days 268 14.0% 349 12.3%
61-90 days 167 8.7% 232 8.2%
3-< 6 months 287 15.0% 474 16.7%
6-< 12 months 239 12.5% 453 15.9%
1-< 2 years 120 6.3% 354 12.5%
≥ 2 years 98 5.1% 262 9.2%
Transplant history
First 1844 96.5% 2761 97.2%
Retransplant 66 3.5% 80 2.8%
Tx type
Heart only 1818 95.2% 2601 91.6%
Heart-lung 28 1.5% 25 0.9%
Heart-kidney 53 2.8% 184 6.5%
Heart-liver 10 0.5% 28 1.0%
Other 1 0.1% 3 0.1%
All recipients 1910 100.0% 2841 100.0%
Table HR 9 Transplant characteristics of adult heart transplant recipi-
ents, 2007 and 2017. Adult heart transplant recipients, including retrans-
plants.
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Donor Recipient CMV EBV HIV
D- R- 16.9% 0.7% 96.9%
D- R+ 21.3% 5.4% 0.3%
D- R unk 0.6% 0.5% 2.3%
D+ R- 23.9% 9.1% 0.0%
D+ R+ 36.0% 77.4% 0.0%
D+ R unk 0.8% 6.7% 0.0%
D unk R- 0.2% 0.0% 0.5%
D unk R+ 0.3% 0.2% 0.0%
D unk R unk 0.0% 0.0% 0.0%
Table HR 10 Adult heart donor-recipient serology matching, 2013-2017.
Donor serology is reported on the OPTN Donor Registration Form and recipi-
ent serology on the OPTN Transplant Recipient Registration Form. There may
be multiple fields per serology. Any evidence for a positive serology is treated
as positive for that serology. If all fields are unknown, incomplete, or pending,
the person is categorized as unknown for that serology; otherwise, serology
is assumed negative. CMV, cytomegalovirus; EBV, Epstein-Barr virus; HIV, hu-
man immunodeficiency virus.
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Characteristic 2007 2017N Percent N Percent
Age
< 1 year 24 9.6% 47 13.5%
1-5 years 83 33.3% 123 35.3%
6-10 years 59 23.7% 58 16.7%
11-17 years 83 33.3% 120 34.5%
Sex
Female 114 45.8% 143 41.1%
Male 135 54.2% 205 58.9%
Race/ethnicity
White 153 61.4% 166 47.7%
Black 38 15.3% 73 21.0%
Hispanic 48 19.3% 81 23.3%
Asian 8 3.2% 17 4.9%
Other/unknown 2 0.8% 11 3.2%
Geography
Metropolitan 208 83.5% 291 83.6%
Non-metro 41 16.5% 57 16.4%
Distance
< 50 miles 123 49.4% 175 50.3%
50-<100 miles 48 19.3% 76 21.8%
100-<150 miles 25 10.0% 49 14.1%
150-<250 miles 26 10.4% 25 7.2%
≥ 250 miles 20 8.0% 18 5.2%
Unknown 7 2.8% 5 1.4%
All candidates 249 100.0% 348 100.0%
Table HR 11 Demographic characteristics of pediatric candidates on the
heart transplant waiting list on December 31, 2007 and December 31,
2017. Candidates aged younger than 18 years waiting for transplant on De-
cember 31 of given year, regardless of first listing date; multiple listings are col-
lapsed. Age calculated at snapshot. Candidates listed as children who turned
18 before the cohort date are excluded.
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Characteristic 2007 2017N Percent N Percent
Diagnosis
Congenital defect 112 45.0% 200 57.5%
Idiopathic dilated CM 56 22.5% 52 14.9%
Familial dilated CM 3 1.2% 8 2.3%
Idiopathic restrictive CM 9 3.6% 18 5.2%
Myocarditis 15 6.0% 7 2.0%
Other/unknown 54 21.7% 63 18.1%
Blood type
A 66 26.5% 91 26.1%
B 25 10.0% 46 13.2%
AB 5 2.0% 9 2.6%
O 153 61.4% 202 58.0%
Medical urgency
Status 1A 43 17.3% 82 23.6%
Status 1B 23 9.2% 72 20.7%
Status 2 52 20.9% 92 26.4%
Inactive status 131 52.6% 102 29.3%
VAD at listing 7 2.8% 28 8.0%
All candidates 249 100.0% 348 100.0%
Table HR 12 Clinical characteristics of pediatric candidates on the heart
transplantwaiting list onDecember 31, 2007andDecember 31, 2017. Can-
didates aged younger than 18 years waiting for transplant on December 31,
2007, and December 31, 2017, regardless of first listing date; multiple listings
are collapsed. Candidates listed as children who turned 18 before the cohort
date are excluded. CM, cardiomyopathy; VAD, ventricular assist device.
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Characteristic 2007 2017N Percent N Percent
Transplant history
First 231 92.8% 327 94.0%
Retransplant 18 7.2% 21 6.0%
Wait time
< 1 year 124 49.8% 220 63.2%
1-< 2 years 35 14.1% 56 16.1%
2-< 3 years 23 9.2% 26 7.5%
3-< 4 years 16 6.4% 21 6.0%
4-< 5 years 8 3.2% 9 2.6%
≥ 5 years 43 17.3% 16 4.6%
Tx type
Heart only 227 91.2% 344 98.9%
Heart-kidney 3 1.2% 4 1.1%
Heart-lung 18 7.2% 0 0.0%
Other 1 0.4% 0 0.0%
All candidates 249 100.0% 348 100.0%
Table HR 13 Listing characteristics of pediatric candidates on the heart
transplantwaiting list onDecember 31, 2007andDecember 31, 2017. Can-
didates aged younger than 18 years waiting for transplant on December 31,
2007, and December 31, 2017, regardless of first listing date; multiple listings
are collapsed. Candidates listed as children who turned 18 before the cohort
date are excluded.
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Waiting list state 2015 2016 2017
Patients at start of year 362 369 367
Patients added during year 645 626 623
Patients removed during year 636 627 606
Patients at end of year 371 368 384
Table HR 14 Heart transplant waitlist activity among pediatric candi-
dates. Candidates concurrently listed at more than one center are counted
once, from the time of earliest listing to the time of latest removal. Candi-
dates who are listed, undergo transplant, and are relisted are counted more
than once. Candidates are not considered to be on the list on the day they are
removed; counts on January 1 may differ from counts on December 31 of the
prior year. Candidates listed for multi-organ transplants are included.
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Removal reason 2015 2016 2017
Deceased donor transplant 464 460 444
Patient died 81 61 67
Patient refused transplant 3 2 0
Improved, transplant not needed 48 60 54
Too sick for transplant 23 28 28
Other 17 16 13
Table HR 15 Removal reason among pediatric heart transplant candi-
dates. Removal reason as reported to the OPTN. Candidates with death dates
that precede removal dates are assumed to have died waiting.
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Characteristic 2005-07 2015-17N Percent N Percent
Age
< 1 year 261 26.9% 368 27.5%
1-5 years 218 22.5% 318 23.8%
6-10 years 128 13.2% 177 13.2%
11-17 years 363 37.4% 474 35.5%
Sex
Female 457 47.1% 584 43.7%
Male 513 52.9% 753 56.3%
Race/ethnicity
White 557 57.4% 693 51.8%
Black 218 22.5% 251 18.8%
Hispanic 135 13.9% 292 21.8%
Asian 44 4.5% 62 4.6%
Other/unknown 16 1.6% 39 2.9%
Insurance
Private 515 53.1% 540 40.4%
Medicaid 364 37.5% 667 49.9%
Other government 63 6.5% 95 7.1%
Unknown 28 2.9% 35 2.6%
Geography
Metropolitan 806 83.1% 1115 83.4%
Non-metro 164 16.9% 222 16.6%
Distance
< 50 miles 506 52.2% 704 52.7%
50-<100 miles 147 15.2% 246 18.4%
100-<150 miles 97 10.0% 138 10.3%
150-<250 miles 95 9.8% 108 8.1%
≥ 250 miles 98 10.1% 110 8.2%
Unknown 27 2.8% 31 2.3%
All recipients 970 100.0% 1337 100.0%
Table HR 16 Demographic characteristics of pediatric heart transplant
recipients, 2005-2007 and 2015-2017. Heart transplant recipients, including
retransplants.
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Characteristic 2005-07 2015-17N Percent N Percent
Diagnosis
Congenital defect 409 42.2% 661 49.4%
Idiopathic dilated CM 294 30.3% 305 22.8%
Familial dilated CM 32 3.3% 83 6.2%
Idiopathic restrictive CM 60 6.2% 61 4.6%
Myocarditis 31 3.2% 33 2.5%
Other/unknown 144 14.8% 194 14.5%
Blood type
A 358 36.9% 480 35.9%
B 118 12.2% 190 14.2%
AB 35 3.6% 42 3.1%
O 459 47.3% 625 46.7%
Medical urgency
Status 1A 726 74.8% 1108 82.9%
Status 1B 129 13.3% 189 14.1%
Status 2 115 11.9% 40 3.0%
On VAD 124 12.8% 334 25.0%
CPRA
< 1% 547 56.4% 526 39.3%
1-< 20% 157 16.2% 198 14.8%
20-< 80% 96 9.9% 266 19.9%
80-< 98% 31 3.2% 72 5.4%
98-100% 34 3.5% 37 2.8%
Unknown 105 10.8% 238 17.8%
All recipients 970 100.0% 1337 100.0%
Table HR 17 Clinical characteristics of pediatric heart transplant recip-
ients, 2005-2007 and 2015-2017. Heart transplant recipients, including re-
transplants. Collection of calculated PRA (CPRA) began March 31, 2015. Prior
to that, measured PRA values were used. CM, cardiomyopathy; VAD, ventric-
ular assist device.
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Characteristic 2005-07 2015-17N Percent N Percent
Wait time
< 31 days 462 47.6% 383 28.6%
31-60 days 177 18.2% 259 19.4%
61-90 days 99 10.2% 190 14.2%
3-< 6 months 135 13.9% 270 20.2%
6-< 12 months 67 6.9% 139 10.4%
1-< 2 years 24 2.5% 66 4.9%
≥ 2 years 6 0.6% 30 2.2%
ABO
Compatible/identical 940 96.9% 1237 92.5%
Incompatible 30 3.1% 100 7.5%
Transplant history
First 893 92.1% 1274 95.3%
Retransplant 77 7.9% 63 4.7%
Tx type
Heart only 945 97.4% 1323 99.0%
Heart-lung 14 1.4% 5 0.4%
Heart-kidney 8 0.8% 7 0.5%
Heart-liver 2 0.2% 2 0.1%
Other 1 0.1% 0 0.0%
All recipients 970 100.0% 1337 100.0%
Table HR 18 Transplant characteristics of pediatric heart transplant re-
cipients, 2005-2007 and 2015-2017. Heart transplant recipients, including re-
transplants.
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Support 2012 2017N Percent N Percent
Any life support 267 71.8% 317 73.4%
Intravenous inotropes 199 53.5% 207 47.9%
Left ventricular assist device 77 20.7% 124 28.7%
Ventilator 64 17.2% 72 16.7%
Extra corporeal membrane oxygenation 19 5.1% 19 4.4%
Right ventricular assist device 18 4.8% 18 4.2%
Prostaglandins 7 1.9% 13 3.0%
Total artificial heart 2 0.5% 1 0.2%
Intra-aortic balloon pump 1 0.3% 2 0.5%
Inhaled NO 1 0.3% 6 1.4%
Table HR 19 Pediatric heart recipients on circulatory support before
transplant. Patients may have more than one type of circulatory support.
80
  
 
Donor Recipient CMV EBV
D- R- 31.3% 15.7%
D- R+ 17.0% 14.6%
D- R unk 0.8% 1.0%
D+ R- 28.5% 27.9%
D+ R+ 20.4% 38.2%
D+ R unk 0.8% 2.2%
D unk R- 0.8% 0.2%
D unk R+ 0.3% 0.1%
Table HR 20 Pediatric heart donor-recipient serology matching, 2013-
2017. Donor serology is reported on the OPTN Donor Registration Form and
recipient serology on the OPTN Transplant Recipient Registration Form. There
may be multiple fields per serology. Any evidence for a positive serology is
treated as positive for that serology. If all fields are unknown, incomplete, or
pending, the person is categorized as unknown for that serology; otherwise,
serology is assumed negative. CMV, cytomegalovirus; EBV, Epstein-Barr virus.
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